DUBLIN, Feb. 23, 2018 /PRNewswire/ --
The "In Vivo Toxicology Market by Product (Instruments, Consumables), (Animal models, Reagents & Kits), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The global in vivo toxicology market is projected to reach USD 6.14 Billion by 2022 from USD 4.40 Billion in 2017, at a CAGR of 6.9%
In this report, the global in vivo toxicology market is segmented by product, testing type, toxicity endpoint, testing facility, and region.
Some key factors driving market growth are the increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests. Factors such as increasing research in oncology and personalized medicine and the rising demand for humanized animal models are expected to offer lucrative opportunities for players in the global market.
Geographically, North America is estimated to dominate the market in 2017 with the highest market share in the in vivo toxicology market. The largest share of this regional segment is attributed to the increasing investments in R&D activities, scientific developments in biotechnology, and the presence of major pharmaceutical and preclinical testing companies in the region.
However, Latin America (LATAM) is expected to grow at the highest CAGR during the forecast period. Factors such as the flourishing pharmaceutical and biopharmaceutical industry in Brazil in turn propelling the drug development activities and increase in the number of CROs that offer cost-effective in vivo toxicology services are driving the growth of the global market in LATAM.
While the overall in vivo toxicology market is expected to grow at a high rate, growing pressures to develop and conduct alternative tests for animal testing and disadvantages associated with animal testing are likely to restrain the growth of this market to a certain extent.
The major players in the global market include Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), Eurofins (Luxembourg), Envigo (US), DSI (US), and The Jackson Laboratory (US).
Market Dynamics
Drivers
- Increasing Pharmaceutical R&D Activities
- Mandatory Government Regulations For Animal Testing
- Innovations In Animal Models
- Exclusive In Vivo Toxicology Tests
Restraints
- Alternative Methods To Animal Testing
- Disadvantages Associated With Animal Toxicology Testing
Opportunities
- Increasing Research In Oncology And Personalized Medicine
- Rising Demand For Humanized Animal Models
Challenges
- Regulations And Laws For The Ethical Use Of Animals In Research
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Premium Insights
5. Market Overview
6. In Vivo Toxicology Market, By Product
7. In Vivo Toxicology Market, By Testing Type
8. In Vivo Toxicology Market, By Toxicity Endpoint
9. In Vivo Toxicology Market, By Testing Facility
10. In Vivo Toxicology Market, By Region
11. Competitive Landscape
12. Company Profiles
- Charles River Laboratories
- Danaher
- Data Sciences International
- Envigo
- Eurofins Scientific
- Labcorp
- Perkinelmer
- Sri International
- Taconic Biosciences
- The Jackson Laboratory
- Wuxi Apptec
For more information about this report visit https://www.researchandmarkets.com/research/q8hdjw/in_vivo?w=5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
